Mesure d'audience ROI frequentation par
About Hybrigenics
Investors Relations
Shares Informations
Press Releases
Documentation
General Meetings
Shareholders
Analyst Coverage
Subscribe Mailing List
Investors Contacts
Presentations
Infos - Medias
Careers
Contact Us
Shareholders
On 31st March 2012
Private placement:
Hybrigenics completed its private placement to institutional investors up to EUR 3.3 million
Hybrigenics and Servier enter into a licence and research collaboration agreement in oncology and other therapeutic fields
Hybrigenics gets approval for a phase II clinical trial of oral inecalcitol in chronic lymphocytic leukemia
investors
Contact Us
Glossary
Site Map
Legal Mentions
English
Français
© 2012 hybrigenics
